Express Pharma
Express Pharma
Browsing tag
lower respiratory tract disease
US FDA expands approval to GSK’s Arexvy for adults aged 50-59, at increased risk
Read more
US FDA approves GSK’s Arexvy, world’s first RSV vaccine for older adults
Read more